WE@HealthTech
Yael Klionsky serves as the General Manager at WIN - Weizmann Innovation Nest since September 2024, while concurrently being a member of WE@HealthTech since February 2021. Prior to this, Yael held the position of Director of Business Development at Yeda - Technology Transfer Company of Weizmann Institute of Science from July 2020 to September 2024, leading the commercialization of Life Sciences technologies. Additional roles include Board Observer at Sentaur Biosciences from September 2020 to July 2024, Project Leader at Compugen from January 2017 to July 2020, Research Scientist at Efranat Ltd. from 2015 to February 2017, and Post-doc researcher in Immunology at the Weizmann Institute from 2014 to 2016. Yael's educational background includes a Ph.D. in Immunology and a Master’s in Transplantation Immunology from the Weizmann Institute, alongside a Bachelor's in Biotechnology and Food Engineering from Technion.
Previous companies
This person is not in the org chart
This person is not in any offices
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.